Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine

Condition:   Risk Reduction Interventions:   Biological: Trivalent Invasive Salmonella Disease Vaccine (6.25 µg);   Biological: Trivalent Invasive Salmonella Disease Vaccine (12 µg);   Biological: Trivalent Invasive Salmonella Disease Vaccine (25 µg);   Biological: Trivalent Invasive Salmonella Disease Vaccine (highest, well-tolerate d dose among Cohorts A-C);   Other: Placebo Sponsor:   University of Maryland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials